NSC 735847

Drug Profile

NSC 735847

Alternative Names: NSC735847

Latest Information Update: 29 May 2017

Price : $50

At a glance

  • Originator ElSohly Laboratories
  • Class Antineoplastics; Oximes; Small molecules
  • Mechanism of Action Apoptosis stimulants; Reactive oxygen species stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Colorectal cancer

Most Recent Events

  • 18 May 2017 ElSohly Laboratories has patent protection for NSC 735847 in USA (ElSohly Laboratories' website, May 2017)
  • 01 Apr 2017 Preclinical trials in Colorectal cancer in USA
  • 01 Apr 2017 Pharmacodynamics data from preclinical studies in Colorectal cancer presented at the 108th Annual Meeting of the American Association for Cancer Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top